Document is current
Any future updates will be listed below
-
Authors
Nicosia, Michael
Miyairi, Satoshi
Beavers, Ashley
Farr, George W.
McGuirk, Paul R.
Pelletier, Marc F.
Valujskikh, Anna
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (RO1-AI113142-01A1)
U.S. Department of Health & Human Services | National Institutes of Health (PO1-AI087586)
- License Information
-
More Information
Article History
Received: 2 January 2019
Accepted: 26 April 2019
First Online: 15 May 2019
Competing Interests
: M.N., S.M., A.B. and A.V. declare no competing interests. We would like to disclose that George Farr, Paul McGuirk and Marc Pelletier are all employees of Aeromics Inc. – provider of AER-270/271, the small molecule AQP4 inhibitor used in the study. All authors concur with the submission.
